New pill targets tough cancers in First-Ever human trial
Disease control
Recruiting now
This is the first study in people to test a new oral medication called RGT-61159. It aims to see if the drug is safe and can help control tumors in adults with advanced adenoid cystic carcinoma or colorectal cancer that has returned or stopped responding to available treatments. …
Phase: PHASE1 • Sponsor: Rgenta Therapeutics Inc • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC